Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS
· Delayed Price · Currency is USD
0.0320
+0.0010 (3.23%)
Dec 23, 2024, 1:22 PM EST
Oncotelic Therapeutics Employees
Oncotelic Therapeutics had 22 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
22
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$211,772
Market Cap
10.96M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 22 | 0 | - |
| Dec 31, 2022 | 22 | 6 | 37.50% |
| Dec 31, 2021 | 16 | 0 | - |
| Dec 31, 2020 | 16 | 3 | 23.08% |
| Dec 31, 2019 | 13 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sandoz Group AG | 22,633 |
| Telix Pharmaceuticals Limited | 234 |
| Elekta AB (publ) | 4,718 |
| Ryman Healthcare Limited | 7,700 |
| Verano Holdings Corp. | 3,900 |
| Vireo Growth Inc. | 490 |
| Medexus Pharmaceuticals Inc. | 82 |
Oncotelic Therapeutics News
- 7 weeks ago - ONCOTELIC CLINICAL PRESENTATIONS AT SITC 2024 - GlobeNewsWire
- 5 months ago - Product Manager Scott Myers to Present at 2nd Global Summit on Artificial Intelligence - GlobeNewsWire
- 7 months ago - ONCOTELIC TO PRESENT AT THE 20TH ANNUAL CONGRESS OF INTERNATIONAL DRUG DISCOVERY SCIENCE & TECHNOLOGY - GlobeNewsWire
- 7 months ago - ONCOTELIC TO PARTICIPATE AT THE BIO INTERNATIONAL 2024 MEETING - GlobeNewsWire
- 7 months ago - ONCOTELIC TO PARTICIPATE AT THE ASCO 2024 MEETING - GlobeNewsWire
- 8 months ago - Mosaic ImmunoEngineering Agrees to Acquire Clinical Necroptosis Cancer Therapy Assets from Oncotelic Therapeutics, Inc. - Accesswire
- 9 months ago - Linkage of Cancer and Lupus in Gliomas Patients - GlobeNewsWire
- 10 months ago - Invitation to Participate in STOP-PC Clinical Trial - GlobeNewsWire